The Lee and BDR decisions signal a shift in the landscape of compulsory licensing in India. This post examines the legal and policy developments leading to these outcomes, highlighting their implications for the Indian pharmaceutical industry.
Read more about Lee and BDR decision – the End of Compulsory Licenses?!